Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy C Jones

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Journal of Personalized Medicine|September 28, 2024
Factors Impacting Intent to Share Multigenic Cancer Testing Results in a Community Hospital SettingWamia Siddiqui, Joel E Pacyna, Sean M Phelan, et al.
Nature Microbiology|March 28, 2025
Publisher Correction: Baloxavir improves disease outcomes in mice after intranasal or ocular infection with Influenza A virus H5N1-contaminated cow's milkJeremy C Jones, Konstantin Andreev, Thomas P Fabrizio, et al.
Mbio|November 15, 2018
Author Correction for Jones et al., "Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors"Jeremy C Jones, Gyanendra Kumar, Subrata Barman, et al.
Mbio|April 26, 2018
Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease InhibitorsJeremy C Jones, Gyanendra Kumar, Subrata Barman, et al.
Influenza and Other Respiratory Viruses|July 30, 2013
Effect of passive immunization on immunogenicity and protective efficacy of vaccination against a Mexican low-pathogenic avian H5N2 influenza virusHeather L Forrest, Alejandro Garcia, Angela Danner, et al.
Frontiers in Oncology|June 6, 2022
Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent GlioblastomaKshama Gupta, Jeremy C Jones, Virginea De Araujo Farias, et al.
Vaccine|February 13, 2017
Evaluation of multivalent H2 influenza pandemic vaccines in miceBrian J Lenny, Stephanie Sonnberg, Angela F Danner, et al.
Targeted Oncology|August 9, 2024
Identifying Actionable Alterations in KRAS Wild-Type Pancreatic CancerAhmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2015
PTHrP-Induced Refractory Malignant Hypercalcemia in a Patient With Chronic Lymphocytic Leukemia Responding to DenosumabAmeen A Salahudeen, Arjun Gupta, Jeremy C Jones, et al.
Antimicrobial Agents and Chemotherapy|July 7, 2016
A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In VitroJeremy C Jones, Bindumadhav M Marathe, Christian Lerner, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Journal of Personalized Medicine|September 28, 2024
Factors Impacting Intent to Share Multigenic Cancer Testing Results in a Community Hospital SettingWamia Siddiqui, Joel E Pacyna, Sean M Phelan, et al.
Nature Microbiology|March 28, 2025
Publisher Correction: Baloxavir improves disease outcomes in mice after intranasal or ocular infection with Influenza A virus H5N1-contaminated cow's milkJeremy C Jones, Konstantin Andreev, Thomas P Fabrizio, et al.
Mbio|November 15, 2018
Author Correction for Jones et al., "Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors"Jeremy C Jones, Gyanendra Kumar, Subrata Barman, et al.
Mbio|April 26, 2018
Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease InhibitorsJeremy C Jones, Gyanendra Kumar, Subrata Barman, et al.
Influenza and Other Respiratory Viruses|July 30, 2013
Effect of passive immunization on immunogenicity and protective efficacy of vaccination against a Mexican low-pathogenic avian H5N2 influenza virusHeather L Forrest, Alejandro Garcia, Angela Danner, et al.
Frontiers in Oncology|June 6, 2022
Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent GlioblastomaKshama Gupta, Jeremy C Jones, Virginea De Araujo Farias, et al.
Vaccine|February 13, 2017
Evaluation of multivalent H2 influenza pandemic vaccines in miceBrian J Lenny, Stephanie Sonnberg, Angela F Danner, et al.
Targeted Oncology|August 9, 2024
Identifying Actionable Alterations in KRAS Wild-Type Pancreatic CancerAhmed Elhariri, Jaydeepbhai Patel, Himil Mahadevia, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2015
PTHrP-Induced Refractory Malignant Hypercalcemia in a Patient With Chronic Lymphocytic Leukemia Responding to DenosumabAmeen A Salahudeen, Arjun Gupta, Jeremy C Jones, et al.
Antimicrobial Agents and Chemotherapy|July 7, 2016
A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In VitroJeremy C Jones, Bindumadhav M Marathe, Christian Lerner, et al.
Pageof 8